Ulipristal acetate
SIGMA/SML1469 - ≥98% (HPLC)
Synonym: (11β)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione; CDB-2914
CAS Number: 126784-99-4
Empirical Formula (Hill Notation): C30H37NO4
Molecular Weight: 475.62
MDL Number: MFCD00899035
Linear Formula: C30H37NO4
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C30H37NO4/c1-18(32)30( |
| InChI key | OOLLAFOLCSJHRE-ZHAKMVSLSA |
| optical activity | [α]/D +165 to +185°, c = 1 in dichloromethane |
| Quality Level | 100 ![]() |
| SMILES string | O=C(C)[C@@]1(OC(C)=O)CC[C |
| solubility | DMSO: 5 mg/mL, clear (warmed) |
| storage temp. | −20°C |
| Biochem/physiol Actions: | Ulipristal acetate is a selective progesterone receptor modulator (SPRM) with tissue-selective partial antagonist activity. It has clinical use both as an emergency contraceptive and as a treatment for uterine fibroids. Ulipristal acetate acts as a partial antagonist on the hypothalamic–pituitary–ov |
| Biochem/physiol Actions: | Ulipristal acetate is a selective progesterone receptor modulator (SPRM); contraceptive and treatment for fibroid tumors. |
| Biochem/physiol Actions: | Ulipristal acetate is known to reduce uncontrolled bleeding due to post uterine fibroid surgery. |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS08 |
| Signal word | Warning |
| Hazard statements | H361fd |
| Precautionary statements | P280 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 51111800 |


